APULI MARICEL (Chief Accounting Officer) sold 1.6% of their position (2K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $132.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2026ACC: 0001470831-26-000225
Officer· Chief Accounting Officer
Since Feb 2026
-2K
Net shares
Net seller
$132.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$66.00
Trade value
$132K
% of position
1.6%
2/26/2026
123.94K→121.94K
Total
Net shares
−2K
Net value
-$132K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | S · Sale | −2K | $66.00 | $132K | 1.6% | 123.94K | 121.94K |
| Total | −2K | -$132K | ||||||
Derivative Transactions0
No derivative transactions reported